Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.
For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Total raised: $90M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Valence Li... | valencefun... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.09.2021 | - | $90M | - | - |
Mentions in press and media 18
| Date | Title | Description | Category | Author | Source |
| 21.11.2022 | Leap Thera... | CAMBRIDGE, Mass., Nov. 21, 202... | - | - | einpresswi... |
| 05.09.2022 | Leap Thera... | Median Progression-Free Surviv... | - | - | einpresswi... |
| 12.11.2021 | Leap Thera... | Leap Therapeutics Reports Thir... | - | - | marketscre... |
| 12.11.2021 | Leap Thera... | CAMBRIDGE, Mass., Nov. 12, 202... | - | - | marketscre... |
| 24.09.2021 | Leap Thera... | CAMBRIDGE, Mass., Sept. 24, 20... | - | - | marketscre... |
| 24.09.2021 | Leap Thera... | Leap Therapeutics Announces Cl... | - | - | marketscre... |
| 22.09.2021 | Leap Thera... | Leap Therapeutics Announces Pr... | - | - | marketscre... |
| 22.09.2021 | Leap Thera... | CAMBRIDGE, Mass., Sept. 22, 20... | - | - | marketscre... |
| 21.09.2021 | Leap Thera... | CAMBRIDGE, Mass., Sept. 21, 20... | - | - | marketscre... |
| 21.09.2021 | Leap Thera... | Leap Therapeutics Announces Pr... | - | - | marketscre... |
Show more